Back

Ten years survival benefit of CABG or PCI based on individual prediction

26 August 2022 (10:45 - 10:55)
Organised by:
Congress Presentation Part of: Coronary intervention: state of the art, complications, and outcomes Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Professor Patrick Washington Serruys

University of Galway, Galway (Ireland)

5 More presentations in this session

Presentation thumbnail
Robotic-assisted PCI - insights from a monocenter registry
Doctor J. Rilinger (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Peri-interventional ischemic stroke after coronary angiography: a large-scale nationwide cohort analysis from 2006 to 2020
Doctor B. Bay (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Coronary perforation incidence and temporal trends (COPIT): systematic review and meta-analysis
Doctor P. Mikhail (Gosford, AU)
Abstract Slides Video
Presentation thumbnail
Stent length and -diameter and long-term clinical outcomes following percutaneous coronary intervention with drug-eluting stent implantation
Ms N. Van Hemert (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Clinical outcome up to 2 years after percutaneous coronary intervention in all-comers with concomitant symptomatic peripheral arterial disease: a pooled analysis in 9,204 randomized trial participants
Miss T. Pinxterhuis (Enschede, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Coronary intervention: state of the art, complications, and outcomes

The Event

Event poster

ESC Congress 2022

26 August 2022 10:45 CET
You may be interested in
thumbnail
Congress Presentation
Ten-year mortality after percutaneous coronary intervention, off-pump and on-pump surgery for complex coronary artery disease - who is the winner?
thumbnail
Congress Presentation
Can machine learning improve risk prediction and individualise decision making between percutaneous and surgical revascularisation?
thumbnail
Congress Presentation
Decision-making in patients eligible for both surgery and percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources